ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

TechCreate to challenge NYSE delisting decision amid trading suspension

Singapore-based payment solutions provider plans appeal after NYSE American panel confirmed delisting over alleged stock manipulation. Trading remains suspended since February 2026.

PA
Priya Anand · Equities & Earnings Desk · 30 Aug 2026 · 08:46 · 1 min read
Share
TechCreate to challenge NYSE delisting decision amid trading suspension

TechCreate Group Ltd. said it will request a review by the New York Stock Exchange Review Committee after the exchange’s Listing Qualifications Panel confirmed a decision to delist its Class A ordinary shares.

The panel cited Sections 1001, 1002(e), and 1003 of the NYSE American Company Guide, concluding the shares were no longer suitable for continued listing. The company, headquartered in Singapore and founded in 2015, provides digital payment infrastructure to financial institutions and businesses.

The delisting process follows a one-day trading suspension ordered by the U.S. Securities and Exchange Commission on February 2, 2026, based on concerns of possible stock manipulation. TechCreate’s shares have remained suspended on NYSE American since then and currently trade over-the-counter under the symbol TCGLF.

TechCreate received notification of the delisting decision on June 12, 2026, and the NYSE panel confirmed the staff’s determination on August 20, 2026. The company has until September 4, 2026, to submit its appeal, which it intends to meet. Neither the SEC nor NYSE American has attributed any responsibility for the alleged manipulation to TechCreate or its executives.

The company stated it has cooperated with regulators regarding the trades and that neither it nor its internal executives were involved in or had knowledge of the alleged manipulation activity. TechCreate emphasized that the delisting process does not affect its operations, customer relationships, or financial position, though it noted there is no guarantee the Review Committee will reverse the panel’s decision.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT